Tags

Type your tag names separated by a space and hit enter

[Gout and hyperuricemia today: prevalence, risk factors, features in the elderly].
Adv Gerontol 2012; 25(3):540-4AG

Abstract

Gout affects more than 1% of adults in the world, and this is the most common form of inflammatory arthritis in men. Accumulating data support an increase in the prevalence of gout that is potentially attributable to recent shifts in diet and lifestyle, improved medical care, and increased longevity. There are both nonmodifiable and modifiable risk factors for hyperuricemia and gout. Nonmodifiable risk factors include age and sex. Gout prevalence increases in direct association with age; the increased longevity of populations in industrialized nations may contribute to a higher prevalence of gout through the disorder's association with age-related diseases such as metabolic syndrome and hypertension, and treatments for these diseases such as thiazide diuretics for hypertension. Although gout is considered to be primarily a male disease, there is a more equal sex distribution among elderly patients. Modifiable risk factors for gout include obesity, the use of certain medications, high purine intake, and consumption of purine-rich alcoholic beverages. The increasing prevalence of gout worldwide indicates that there is an urgent need for improved efforts to identify patients with hyperuricemia early in the disease process, before the clinical manifestations of gout become apparent.

Authors

No affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

English Abstract
Journal Article
Review

Language

rus

PubMed ID

23289237

Citation

Ar'ev, A L., et al. "[Gout and Hyperuricemia Today: Prevalence, Risk Factors, Features in the Elderly]." Advances in Gerontology = Uspekhi Gerontologii, vol. 25, no. 3, 2012, pp. 540-4.
Ar'ev AL, Kunitskaia NA, Kozina LS. [Gout and hyperuricemia today: prevalence, risk factors, features in the elderly]. Adv Gerontol. 2012;25(3):540-4.
Ar'ev, A. L., Kunitskaia, N. A., & Kozina, L. S. (2012). [Gout and hyperuricemia today: prevalence, risk factors, features in the elderly]. Advances in Gerontology = Uspekhi Gerontologii, 25(3), pp. 540-4.
Ar'ev AL, Kunitskaia NA, Kozina LS. [Gout and Hyperuricemia Today: Prevalence, Risk Factors, Features in the Elderly]. Adv Gerontol. 2012;25(3):540-4. PubMed PMID: 23289237.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Gout and hyperuricemia today: prevalence, risk factors, features in the elderly]. AU - Ar'ev,A L, AU - Kunitskaia,N A, AU - Kozina,L S, PY - 2013/1/8/entrez PY - 2013/1/8/pubmed PY - 2013/1/23/medline SP - 540 EP - 4 JF - Advances in gerontology = Uspekhi gerontologii JO - Adv Gerontol VL - 25 IS - 3 N2 - Gout affects more than 1% of adults in the world, and this is the most common form of inflammatory arthritis in men. Accumulating data support an increase in the prevalence of gout that is potentially attributable to recent shifts in diet and lifestyle, improved medical care, and increased longevity. There are both nonmodifiable and modifiable risk factors for hyperuricemia and gout. Nonmodifiable risk factors include age and sex. Gout prevalence increases in direct association with age; the increased longevity of populations in industrialized nations may contribute to a higher prevalence of gout through the disorder's association with age-related diseases such as metabolic syndrome and hypertension, and treatments for these diseases such as thiazide diuretics for hypertension. Although gout is considered to be primarily a male disease, there is a more equal sex distribution among elderly patients. Modifiable risk factors for gout include obesity, the use of certain medications, high purine intake, and consumption of purine-rich alcoholic beverages. The increasing prevalence of gout worldwide indicates that there is an urgent need for improved efforts to identify patients with hyperuricemia early in the disease process, before the clinical manifestations of gout become apparent. SN - 1561-9125 UR - https://www.unboundmedicine.com/medline/citation/23289237/[Gout_and_hyperuricemia_today:_prevalence_risk_factors_features_in_the_elderly]_ L2 - https://medlineplus.gov/gout.html DB - PRIME DP - Unbound Medicine ER -